CD4 and Opportunistic infection: Cotrimoxazole prophylactic therapy is a recommended prophylaxis of opportunistic infections in patients with severe or advanced HIV clinical disease (WHO stage 3 or 4) and/or for a CD4 count ≤ 350 cells/mm3 (WHO, 2014).